Company
At Aquyre Biosciences, we recognize the limitations in point of care biopsy assessment contributes largely to the delay of patient’s treatment. Our mission is to eliminate the uncertainty, inaccuracy and delay of biopsy assessment and diagnosis, while maximizing Diagnostic Yield and Sufficiency for Next Generation Sequencing.
Leadership
At Aquyre Biosciences, we recognize the limitations in point of care biopsy assessment contributes largely to the delay of patient’s treatment. Our mission is to eliminate the uncertainty, inaccuracy and delay of biopsy assessment and diagnosis, while maximizing Diagnostic Yield and Sufficiency for Next Generation Sequencing.
Greg Bowles
Nicholas Mancini
CJ Jiang
Al Talavera
Interested in learning more about Van Gogh?
Improving patient outcomes by democratizing the rapid and accurate diagnosis of cancer patients
Greg Bowles
Chief Executive Officer
Greg Bowles brings over two decades of expertise in the medical technologies sector to his role at Aquyre Biosciences. With a career that spans from pioneering contributions at Intuitive Surgical, where he excelled as Capital Sales Manager for the daVinci Robot in Michigan, to impactful positions at EndoGastric Solutions as Regional Manager and then Vice President of Sales, Greg's journey in the MedTech industry is marked by leadership and innovation. His entrepreneurial spirit led him to co-found and co-invent at FlexDex Surgical, a venture from the University of Michigan, where he initially served as General Manager before taking on the role of Chief Marketing Officer, steering the company's marketing and sales strategies to new heights.
At Aquyre Biosciences, as Senior Vice President of Sales and Marketing, Greg has been pivotal in advancing the company’s commercial efforts, particularly in the clinical validation of Aquyre’s unique technology through successful clinical trials and its introduction into the market, securing product adoption by both community and academic hospitals across the U.S. Before embarking on his industry career, Greg dedicated 15 years to serving in the U.S. Navy and the National Security Agency as a cryptologist, where he managed significant government programs and collaborated with international agencies to support global operations, showcasing his diverse skills and commitment to excellence.
Nicholas Mancini
Chief Development Officer
Nicholas Mancini, a seasoned Medical Device industry executive, boasts over 19 years of comprehensive experience in sales, marketing, and training within the MedTech sector. His expertise spans across roles in Fortune 100 corporations and dynamic early-stage startups. Currently at Aquyre Biosciences, Mancini leverages his vast experience to drive innovation and market penetration.
His notable contributions include playing a crucial role in the successful acquisition of his previous startups, SurgiQuest, Inc. and Z-Medica LLC, marking significant milestones in his career. These ventures have honed his skills in commercializing and launching groundbreaking technologies into the capital and disposable sectors of the healthcare market. Mancini's exceptional leadership abilities have been instrumental in forming, guiding, and enhancing top-tier sales teams, underscoring his consistent track record of fostering growth and driving success in the MedTech industry.
CJ Jiang
Chief Operating Officer
CJ Jiang brings over twenty years of expertise in engineering and management to Aquyre Biosciences, where he focuses on advancing medical imaging, computer vision, and machine learning for medical diagnostics. His leadership has been pivotal in directing product development, enhancing operations, improving product quality and efficacy, and enforcing stringent quality systems. Jiang's role involves steering advanced R&D projects, showcasing his commitment to innovation and excellence in the medical technology sector.
At Aquyre Biosciences, Jiang's exceptional interpersonal, leadership, teamwork, and communication skills shine as he builds and manages high-performance, cross-disciplinary teams. His dedication to fostering a collaborative work environment and his ability to drive innovation and efficiency have been instrumental in Aquyre Biosciences' growth and success in the highly competitive field of medical diagnostics.
Al Talavera
Chief Financial Officer
Al Talavera brings over three decades of financial expertise to Aquyre Biosciences, distinguished by his certifications as a Public Accountant, Management Accountant, and Internal Auditor. His career encompasses significant roles such as CFO, Corporate Controller, Board Member, and Audit Committee Member, reflecting his broad skill set across financial strategies and corporate governance.
Within both startup ventures and Fortune 100 companies, Talavera has been instrumental in navigating mergers, acquisitions, restructuring, IPOs, and ensuring compliance with financial reporting, SEC filings, and SOX readiness. His strategic financial leadership at Aquyre Biosciences is vital in steering the company towards sustainable growth and operational excellence in the dynamic field of biotechnology.
